Alpine Immune Sciences, Inc.
8 clinical trials · Sponsor
◉ Watch Alpine Immune Sciences, Inc.
| Record | Firm | Date |
|---|---|---|
| An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (NCT05757570) | Alpine Immune Sciences, Inc. | 2023-07-03 |
| An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases (NCT05732402) | Alpine Immune Sciences, Inc. | 2023-03-15 |
| A Study of ALPN-303 in Adult Healthy Volunteers (NCT05034484) | Alpine Immune Sciences, Inc. | 2021-11-15 |
| ALPN-202 With PD-1 Inhibition in Advanced Malignancies (NCT04920383) | Alpine Immune Sciences, Inc. | 2021-06-22 |
| An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies (NCT04186637) | Alpine Immune Sciences, Inc. | 2020-06-02 |
| ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD (NCT04227938) | Alpine Immune Sciences, Inc. | 2020-05-11 |
| Cell Surface Marker Expression in Autoimmune Diseases (NCT03757065) | Alpine Immune Sciences, Inc. | 2019-06-12 |
Track Alpine Immune Sciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.